Increased <i>bla</i> <sub>KPC</sub> Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical Isolate
Paolo Gaibani, Gabriele Bianco, Stefano Amadesi, Matteo Boattini, Simone Ambretti, Cristina Costa
Abstract
Herein, we report the in vivo evolution of imipenem/relebactam-resistance in KPC-producing K. pneumoniae (KPC-Kp) isolated from a critically-ill patient treated with multiple combination therapies based on ceftazidime-avibactam or meropenem-vaborbactam. Imipenem/relebactam-resistance was associated to meropenem-vaborbactam cross-resistance and was due to truncated OmpK35 and OmpK36 porins and increased copy of bla KPC copy number.
Topics & Concepts
MeropenemKlebsiella pneumoniaeImipenemMicrobiologyBiologyKlebsiellaVirologyAntibiotic resistanceAntibioticsGeneticsGeneEscherichia coliAntibiotic Resistance in BacteriaInfections and bacterial resistanceMycobacterium research and diagnosis